Fibrinogen interaction with the red blood cell membrane

Clinical Hemorheology and Microcirculation

Volumn 53, Issue 1-2, 2013, Pages 39-44

  Saldanha, Carlota ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

CD47; erythrocte deformability; erythrocyte aggregation; Fibrinogen; nitric oxide

Indexed keywords

FIBRINOGEN; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE;

BINDING SITE; ENZYME PHOSPHORYLATION; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FIBRINOGEN BLOOD LEVEL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD47; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; FIBRINOGEN; HUMANS; MALE; NITRIC OXIDE;

EID: 84872954886     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1574     Document Type: Review

References (50)

1. E.V.D. Akker, J. Timothy, J. Satchwell, C.R.C.Williamson and A.M. Toye, Band 3 multiprotein complexes in the red blood cell membrane; of mice and men, Blood Cells Molec Dis 45 (2010), 1-8.
2. J.P. Almeida, F.A. Carvalho, T. Freitas and C. Saldanha, Modulation of hemorheological parameters by the erythrocyte redox thiol status, Clin Hemorheol Microcirc 40 (2008), 99-111.
3. J.P. Almeida, T. Freitas and C. Saldanha, Erythrocyte deformability dependence on band 3 protein in a in vitro modelo f hyperfibrinogenemia, Clin Hemorheol Microcirc 50 (2012), 213-219.
4. R.B. Ami, G. Barshtein, D. Zeltser, Y. Goldberg, I. Shapia, A. Roth, G. Keren, H. Miller, V. Prochorov, A. Eldor, S. Berliner and S. Yedgar, Parameters of red blood cell aggregation as correlates of the inflammatory state, Am J Physiol Heart Circ Physiol 280 (2001), H1982-H1988.
5. E.B. Assayag, N. Bornstein, I. Shapira, T. Mardi, Y. Goldin, T. Tolshinski, Y. Vered, V. Zakuth, M. Burke, S. Berliner and D.S. Bonet, Inflammation-sensitive proteins and erythrocyte aggregation in atherothrombosis, Int J Cardiol 98 (2005), 271-276.
6. E.B. Assayag, I.Bova, S. Berliner,H. Peretz, S. Usher, I. Shapira and N.M. Bornstein, Gender differences in the expression of erythrocyte aggregation in relation to B-fibrinogen gene polymorphism in apparently healty individuals, Thromb Haemost 95 (2006), 428-433.
7. O.K. Baskurt and H.J. Meiselman, Red blood cell aggregability, Clin Hemorheol Microcirc 43 (2009), 353-354.
8. B. Blomb?ack, Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis, Thromb Res 83 (1996), 1-75.
9. C.L. Carty, M. Cushman, D. Jones, L.A. Lange, L.A. Hindorff, K. Rice, N.S. Jenny, J.P. Durda, J. Walston, C.S. Carlson, D. Nickerson, R.P. Tracy and A.P. Reiner, Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The cardiovascular healthy study, Thromb Haemost 99 (2008), 388-395.
10. F.A. Carvalho, J.P. Almeida, I.O. Fernandes, T. Freitas-Santos and C. Saldanha, Non-neuronal cholinergic system and signal transduction pathways mediated by band 3 in red blood cells, Clin Hemorheol Microcirc 40 (2008), 207-217.
11. F.A. Carvalho, S. Connell, G. Miltenberger-Miltenyi, S.V. Pereira, A. Tavares, R.A. Ariens and N.C. Santos, Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes, ACS nano 4 (2010), 4609-4620.
12. F.A. Carvalho, S. de Oliveira, T. Freitas, S. Goncalves and N.C. Santos, Variations on fibrinogen-erythrocyte interactions during cell aging, PLoS One 6 (2011), e18167.
13. F.A. Carvalho, J.P. Lopes de Almeida, T. Freitas-Santos and C. Saldanha, Modulation of erythrocytes acetylcholinesterase activity and its association with G protein. Band 3 interactions, J Membr Biol 228 (2009), 89-97.
14. S. De Oliveira, V. Vitorino de Almeida, A. Calado and C. Saldanha, Integrin- associated protein (CD47) is a putative mediator for soluble fibrinogen interaction with human red blood cells membrane, Biochem Biophys Acta 1818 (2012), 481-490.
15. J. Dormandy, E. Ernst, A. Matrai and P.T. Flute, Hemorheological changes following acute myocardial infarction, Am Heart J 104 (1982), 1364-1367.
16. G.H. Fey and G.M. Fuller, Regulation of the acute phase gene expression by inflammatory mediators, Mol Bio Med 4 (1987), 323-328.
17. I. Gonçalves, C. Saldanha and J. Martins e Silva, β-estradiol effect on erythrocyte aggregation-a controlled in vitro study, Clin Hemorheol Microcirc 25 (2001), 127-134.
18. S. Gonçalves, N.C. Santos, J. Martins-Silva and C. Saldanha, Fluorescence spectrocospy evaluation of fibrinogen-estradiol binding, J Photochem Photob B: Biology 86 (2007), 170-176.
19. T. Gori, Viscosity, platelet activation, and hematocrit: Progress in understanding their relationship with clinical and subclinical vascular disease, Clin Hemorheol Microcirc 49 (2011), 37-42.
20. P.J. Haidaris, C.W. Francis, L.A. Sporn, D.S. Arvan, F.A. Collichio andV.J. Marder,Megakaryocytes and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocye-specific expression of gamma chain-variant polypeptides, Blood 74 (1989), 743-750.
21. J. Hassan, C. Chelucci and V. Sorrentino, Transforming growth factor b (TGF-b) inhibits the expression of fibrinogen and factor VII in a hepatoma cell line, Thromb Haemost 67 (1992), 478-483.
22. B. Holm, D.W. Nilsen and H.C. Godal, Evidence that low molecular fibrinogen (LMW) is formed by degradation of high molecular weight fibrinogen (HMW), Thromb Res 41 (1986), 879-884.
23. J.A. Kant, A.J. Fornace, D. Saxe, M.I. Simon, O.W. McBride and G.R. Crabtree, Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion, Proc Natl Acad Sci U S A 82 (1985), 2344-2348.
24. D. Lominadze and W.L. Dean, Involvement of fibrinogen specific binding in erythrocyte aggregation, FEBS Lett 517 (2002), 41-44.
25. J.P. Lopes de Almeida, T. Freitas-Santos and C. Saldanha, Evidence that the degree of band 3 phosphorylation modulates human erythrocytes nitric oxide efflux-in vitro model of fibrinogenemia, Clin Hemorheol Microcirc 49 (2011), 407-416.
26. J.P. Lopes de Almeida, T. Freitas-Santos and C. Saldanha, Fibrinogen-dependent signaling in microvascular erythrocyte function: Implications on nitric oxide flux, J Memb Biol 231 (2009), 47-53.
27. R.S. Lovely, L.A. Falls, H.A. Al-Mondhiry, C.E. Chambers, G.J. Sexton, H. Ni and D.H. Farrell, Association of -A/-fibrinogen levels and coronary artery disease, Thromb Haemost 88 (2002), 26-31.
28. N. Maeda, M. Seik, Y. Suzuki and T. Shiga, Effect of pH on the velocity of erythrocyte aggregation, Biorheology 25 (1988), 25-30.
29. G. Margurie and N. Ardaillou, Potential role of the A - chain in the binding of calcium to human fibrinogen, Biochim Biophys Acta 701 (1982), 410-412.
30. M. Minetti, L. Agati and W. Malorni, The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenic implications for vascular diseases, Cardiovasc Res 75 (2007), 21-28.
31. A.V. Muravyov, S.V. Bulaeva, I.A. Tikhomirova, A.V. Zamishlayev, E.V. Uzikova and M.J. Miloradov, Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: The molecular change mechanisms after pentoxifylline treatment, Clin Hemorheol Microcirc 49 (2011), 431-439.
32. M. Musielak and J. Loscielak, Aggregation properties of the Aalpha (2), Bbeta(2), gama (A2) and Aalpha (2), Bbeta(2) gamma (A) subpopulations of human fibrinogen, Clin Hemorheol Microcirc 35 (2006), 301-303.
33. B. Neu and H.J. Meiselman, Depletion mediated red blood cell aggregation in polymer solutions, Biophys J 83 (2002), 2482-2490.
34. C. Rainer, D.T. Kawanishi, P.A.N. Chandraratna, R.M. Bauersachs, C.L. Reid and H.J. Meiselman, Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease, Circulation 76 (1987), 15-20.
35. M.W. Rampling, H.J. Meiselman, B. Neu and O.K. Baskurt, Influence of cell-specific factors on red blood cell aggregation, Biorheology 41 (2004), 91-112.
36. C. Saldanha, T. Freitas and J.P. Almeida, Fibrinogen effects on erythrocyte nitric oxide mobilization in presence of acetylcholine, Life Sci 2012 Jul 11. [Epub ahead of print].
37. C. Saldanha, T. Freitas-Santos and J.P. Lopes de Almeida, CD47 agonist peptide effects on human erythrocyte nitric oxide mobilization in presence of fibrinogen Poster presentation (P002), Program and Abstract Book, pp77 of the XXIInd International Fibrinogen Workshop July 4-6, 2012 Brighton, UK.
38. C. Saldanha, J. Loureiro, C. Moreira and J.M. Silva, Behaviour of human erythrocyte aggregation in presence of autologous lipoproteins, Biochem Res Int 2012;2012:261736. Epub 2011 Sep 8.
39. C. Saldanha and J. Martins e Silva (1991) Effect of plasma osmolality on erythrocyte aggregation index. H́emorheologie et aggregation erythrocytaire", vol 3 Th́eories et applications cliniques. J.F. Stoltz, M. Donner, A.L. Copley (eds) Editions Medicales Internationales, pp. 142-145.
40. C. Saldanha, A.S. Silva and S. Gonçalves, Modulation of erythrocyte hemorheological properties by band 3 phosphorylation and dephosphorylation, Clin Hemorheol Microcirc 36 (2007), 183-194.
41. K.R. Siebenlist, D.A. Meh and M.W. Mosesson, Plasma factor XIII binds specifically to fibrinogen molecules containing - chain, Biochemistry 35 (1996), 10448-10453.
42. M.I. Spengler, M.J. Svetaz, M.B. Leroux, S.M. Bertoluzzo, P. Carrara, F. Van Isseldyk, D. Petrelli, F.M. Parente and P. Bosch, Erythrocyte aggregation in patients with systemic lupus erythematosus, Clin Hemorheol Microcirc 47(4) (2011), 279-285. doi: 10.3233/CH-2011-14099
43. G.A. Tennent, S.O. Brennan, A.J. Stangou, J. O'Grady, P.N. hawkins and M.B. Pepys, Human plasma fibrinogen is synthesized in the liver, Blood 109 (2007), 1971-1974.
44. A.E. Thomas, F.R. Gree, C.H. Kellecher, H.C. Wilkes, P.J. Brennan, T.W. Meade and S.E. Humphries, Variation in the promoter variation of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non smokers, Thromb Haemost 65 (1991), 487-490.
45. A. Vaýa, J. Calvo, C. Alcaĺa, L. Mićo, J. Todoĺi and J.M. Ricart, Rheological alterations and thrombotic events in patients with systemic lupus erythematosus, Clin Hemorheol Microcirc 51 (2012), 51-58.
46. A. V́aya, A. Héandez-Mijares, R. Sendra, E. Soĺa, R. Soĺa, D. Corella and B. Laiz, Association between hemorheological alterations and metabolic syndrome, Clin Hemorheol Microcirc 49 (2011), 493-503.
47. A. V́aya, A. Héandez-Mijares, M. Suescun, E. Soĺa, R. Ćamara, M. Romagnoli, D. Bautista and B. Laiz, Metabolic alterations in morbid obesity. Influence on the haemorheological profile, Clin Hemorheol Microcirc 48 (2011), 247-255.
48. I. Velcheva, E. Titianova and N. Antonova, Influence of hemorheological parameters and mean blood pressure on carotid blood flow asymmetry in patients with chronic unilateral cerebral infarctions, Clin Hemorheol Microcirc 45 (2010), 239-244.
49. U.Windberger, A. Bartholovistsch, R. Plasenzotti, K.J. Korak and G. Heinze, Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammaliam species: Reference values and comparation of data, Exp Physiol 88 (2003), 431-440.
50. G. Yardin and H.J. Meiselman, Effects of cellular morphology on the viscoelastic behaviour of high hematocrit RBC suspensions, Biorheology 26 (1989), 153-175.